February 4, 2019
Analysis of thousands of individual cells in multiple myeloma patients allows for a much more precise diagnosis — distinguishing asymptomatic, early-stage patients from those with full-blown disease — and may guide treatment choices toward a more personalized approach, a study shows. The study, “Single cell dissection of plasma cell heterogeneity in symptomatic and asymptomatic myeloma,” was published...
Continue Reading

Floor 7, 90 The Terrace
Wellington Central
New Zealand